Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Shigella Surveillance Study.

Vannice K. et al, (2024), Open forum infectious diseases, 11, S1 - S5

IgG Serum Antibodies to Shigella sonnei Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven S. sonnei Shigellosis in Israeli Children and Adolescents.

Asato V. et al, (2024), Vaccines, 12

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.

Giersing BK. et al, (2023), The Lancet. Global health, 11, e1819 - e1826

A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.

Van Puyvelde S. et al, (2023), Nat Commun, 14

Salmonella Combination Vaccines: Moving Beyond Typhoid

MacLennan CA. et al, (2023), Open Forum Infectious Diseases, 10, S58 - S66

Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coli.

Beriotto I. et al, (2023), Microbiology spectrum, 11

Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections

Abuga KM. et al, (2023), Wellcome Open Research, 8, 48 - 48

Consequences of Shigella infection in young children: a systematic review.

Libby TE. et al, (2023), Int J Infect Dis

Complementary measurement of nontyphoidal Salmonella-specific IgG and IgA antibodies in oral fluid and serum.

Elias SC. et al, (2023), Heliyon, 9

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.

Micoli F. et al, (2023), Frontiers in molecular biosciences, 10

Immune responses to Neisseria gonorrhoeae and implications for vaccine development.

Belcher T. et al, (2023), Frontiers in immunology, 14

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

Jossi SE. et al, (2023), Frontiers in Immunology, 14

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.

Cohen D. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Impact and Control of Sugar Size in Glycoconjugate Vaccines.

Stefanetti G. et al, (2022), Molecules (Basel, Switzerland), 27

Frontiers in Shigella Vaccine Development.

MacLennan CA. and Steele AD., (2022), Vaccines, 10

The Shigella Vaccines Pipeline.

MacLennan CA. et al, (2022), Vaccines, 10

Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the Congo.

Van Puyvelde S. et al, (2022), mBio

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.

Pavlinac PB. et al, (2022), Vaccines, 10

The Background, Role and Approach for Development of a Controlled Human Infection Model for Nontyphoidal Salmonella.

MacLennan CA., (2021), Current topics in microbiology and immunology

An adsorption method to prepare specific antibody-depleted normal human serum as a source of complement for human serum bactericidal assays for Salmonella.

Siggins MK. and MacLennan CA., (2021), Vaccine

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?